DC
Dr. C. Nandi
Executive
Other
Discover the detailed record of transactions filed by Dr. C. Nandi, Executive. Director active across 1 company, notably NOCIL Limited. Cumulatively, 7 disclosures have been recorded. Activity tracked since 1 June 2021. The latest transaction was filed on 27 August 2021 (Sale). Regulator: SEBI (PIT + SAST). The full history is openly available.
Companies and markets linked to Dr. C. Nandi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
5,000 shares@ ₹276.610.0001% mcap4.9% of flowEquity SharesSEBI:e8970eba1907f3abf68c3a97d6ce7f3623f3fe01
29,575 shares@ ₹170.03660.0002% mcap17.9% of flowEquity SharesSEBI:bf63962080004d9e8e65080143d0f559282013a6
9,518 shares@ ₹290.000.0001% mcap9.8% of flowEquity SharesSEBI:08d9fa4e796979dcc89a7c58aafd466401f3307c
25,000 shares@ ₹221.6240.0002% mcap19.5% of flowEquity SharesSEBI:883f888a2ff6bba1305822eb42fa2ab8164c3d9d
10,000 shares@ ₹212.29920.0001% mcap7.5% of flowEquity SharesSEBI:a7603342a0a8fc947867dccc2e21bccd4e3fd369
40,282 shares@ ₹203.67890.0003% mcap28.7% of flowEquity SharesSEBI:0154a7bb5eb790dd0f49cf426f1b007b5401efe5
39,850 shares@ ₹84.050.0001% mcap11.7% of flowEquity SharesSEBI:ac9999d4433d26c9415b13ba0c67919c8b79b1a6
About Dr. C. Nandi
Dr. C. Nandi is an executive at NOCIL Limited, a company specializing in manufacturing chemical products. He plays a key role in managing the company's operations and strategic development. NOCIL Limited is known for its innovation in the chemical sector, and Dr. C. Nandi contributes to its success and growth in the market.